z-logo
Premium
Synthesis of 14 C‐labeled piperidines and application to synthesis of [ 14 C]SCH 351125, a CCR5 receptor antagonist
Author(s) -
Ren Sumei,
McNamara Paul,
Royster Pernilla,
Lee Jae,
Saluja Surinderjit S.,
Koharski David,
Hendershot Sharon,
Truong Van
Publication year - 2007
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1306
Subject(s) - chemistry , iminium , piperidine , intramolecular force , stereochemistry , atropisomer , cationic polymerization , chemical synthesis , antagonist , yield (engineering) , medicinal chemistry , ion , receptor , organic chemistry , in vitro , biochemistry , materials science , metallurgy
1‐Benzyl‐4‐hydroxy[2‐ 14 C]piperidine, a useful intermediate in labeled compound synthesis, was prepared from [ 14 C]formaldehyde in high yield. The distribution pattern of 14 C in the product is consistent with a mechanism involving reversible iminium ion formation and rapid equilibration of the iminium ion through a cationic aza‐Cope rearrangement. These steps precede the rate‐determining intramolecular cyclization step. SCH 351125 is a potent, selective CCR5 receptor antagonist with potential as a treatment for HIV infection. [ 14 C]SCH 351125, required for metabolism studies, was prepared from 1‐benzyl‐4‐hydroxy[2‐ 14 C]piperidine in six steps. [ 14 C]SCH 351125 is a mixture of four atropisomers. Preparation of [ 14 C]SCH 351125 besylate salt of the desired atropisomer pair is also described. Copyright © 2007 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom